Related Experiment Videos
Cx32 mRNA in rat liver: effects of inflammation on poly(A) tail distribution and mRNA degradation
1Division of Pediatric Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Abstract:
Previous studies showed that the expression of connexin 32 (Cx32), the polypeptide subunit component of the major hepatic gap junction, is reduced in liver by changes in mRNA stability during bacterial lipopolysaccharide (LPS)-induced inflammation. In this study, we examined the distribution of Cx32 mRNA poly(A) tail lengths during LPS-induced inflammation, because this is considered the first step in the degradation of many mRNAs. During LPS treatment the first detectable change in Cx32 mRNA was a gradual shortening of its poly(A) tail, which reached a final size of approximately 20 nucleotides. However, the poly(A) tail did not disappear entirely before the bulk of Cx32 mRNA was degraded. Treatment with actinomycin D, which blocks the degradation of Cx32 mRNA after LPS administration, resulted in the appearance of a completely deadenylated mRNA, which otherwise could not be detected. On the contrary, treatment with cycloheximide resulted in a decrease in the stability of Cx32 mRNA without an apparent change of the poly(A) tail size. The effect of cycloheximide on Cx32 mRNA stability seems to be due indirectly to the induction of an inflammatory response by this drug. These results suggest that, similar for many mRNAs, shortening of the poly(A) tail is one of the first steps in the degradation of Cx32 mRNA during inflammation.
Insights
Bacterial lipopolysaccharide (LPS) inflammation shortens connexin 32 (Cx32) mRNA poly(A) tails, initiating degradation. This poly(A) tail shortening is an early step in Cx32 mRNA decay during inflammation.
Area of Science:
- Molecular Biology
- Cell Biology
- Hepatology
Background:
- Connexin 32 (Cx32) is crucial for hepatic gap junctions.
- Cx32 expression decreases during inflammation due to mRNA instability.
- Polyadenylation is a key regulator of mRNA stability and degradation.
Purpose of the Study:
- To investigate Cx32 mRNA poly(A) tail length changes during lipopolysaccharide (LPS)-induced inflammation.
- To determine the role of poly(A) tail shortening in Cx32 mRNA degradation.
Main Methods:
- Utilized bacterial lipopolysaccharide (LPS) to induce inflammation in a model system.
- Analyzed Cx32 mRNA poly(A) tail lengths using molecular techniques.
- Administered actinomycin D and cycloheximide to assess mRNA degradation pathways.
Main Results:
- LPS treatment caused gradual shortening of the Cx32 mRNA poly(A) tail to ~20 nucleotides.
- Poly(A) tail shortening preceded complete Cx32 mRNA degradation.
- Actinomycin D stabilized Cx32 mRNA, revealing a deadenylated form.
- Cycloheximide decreased Cx32 mRNA stability without altering poly(A) tail length, likely via indirect inflammatory effects.
Conclusions:
- Poly(A) tail shortening is an initial event in Cx32 mRNA degradation during inflammation.
- Cx32 mRNA decay during inflammation involves mechanisms similar to other eukaryotic mRNAs.
- Understanding these mechanisms is vital for hepatic inflammation research.